The effect of pore size on cell adhesion in collagen-GAG scaffolds | Biomaterials | 2005 | 1K |
Controlled microfluidic interfaces | Nature | 2005 | 745 |
The role of IL-6 and STAT3 in inflammation and cancer | European Journal of Cancer | 2005 | 714 |
Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial | Journal of Clinical Oncology | 2005 | 599 |
Proliferation marker Ki-67 in early breast cancer | Journal of Clinical Oncology | 2005 | 593 |
An objective definition of a vortex | Journal of Fluid Mechanics | 2005 | 584 |
Extension of the visualization tool MapMan to allow statistical analysis of arrays, display of corresponding genes, and comparison with known responses | Plant Physiology | 2005 | 514 |
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations | British Journal of Cancer | 2005 | 443 |
Growth of nano-scale hydroxyapatite using chemically treated titanium oxide nanotubes | Biomaterials | 2005 | 411 |
Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase | Journal of Clinical Oncology | 2005 | 368 |
Intestinal growth and differentiation in zebrafish | Mechanisms of Development | 2005 | 338 |
Intensive lifestyle changes may affect the progression of prostate cancer | Journal of Urology | 2005 | 314 |
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20 | European Journal of Cancer | 2005 | 305 |
Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg | European Journal of Cancer | 2005 | 298 |
Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial | Circulation | 2005 | 295 |
Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer | Journal of Clinical Oncology | 2005 | 286 |
Molecular genetics of acute lymphoblastic leukemia | Journal of Clinical Oncology | 2005 | 281 |
Food insufficiency and women's mental health: findings from a 3-year panel of welfare recipients | Social Science and Medicine | 2005 | 265 |
Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene | Laboratory Investigation | 2005 | 258 |
CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma | Blood | 2005 | 243 |
Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner | Blood | 2005 | 235 |
Optimal Inequalities in Probability Theory: A Convex Optimization Approach | SIAM Journal on Optimization | 2005 | 234 |
Managing patients treated with bevacizumab combination therapy | Oncology | 2005 | 232 |
Differential sensitivity of liposarcoma subtypes to chemotherapy | European Journal of Cancer | 2005 | 228 |
Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists | Journal of Clinical Oncology | 2005 | 228 |